Finding the right patient with AI
LG Chem is developing AI models to identify biomarkers that predict treatment responses and help select patients for clinical trials, a key part of the company's precision oncology strategy.
"Future competitiveness in drug development depends not only on finding the right drug, but also on identifying the right patient through AI." – Son Jee-woong
A vaccine designed for each individual
LG Chem's personalised cancer vaccine programme uses AI to predict each patient's specific neoantigens. These are molecules found only on cancer cells that can help the immune system recognise and attack tumours.
















